HCM
BSX icon

Hollencrest Capital Management’s Boston Scientific BSX Stock Holding History

Hollencrest Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.4K Hold
1,181
– – ﹤0.01% 568
2026
Q1 		$74.1K Hold
1,181
– – ﹤0.01% 479
2025
Q4 		$113K Hold
1,181
– – ﹤0.01% 426
2025
Q3 		$115K Hold
1,181
– – ﹤0.01% 408
2025
Q2 		$127K Hold
1,181
– – 0.01% 356
2025
Q1 		$119K Sell
1,181
-147
-11% -$14.8K 0.01% 355
2024
Q4 		$119K Hold
1,328
– – ﹤0.01% 378
2024
Q3 		$111K Buy
1,328
+147
+12% +$11.6K ﹤0.01% 369
2024
Q2 		$90.9K Hold
1,181
– – ﹤0.01% 410
2024
Q1 		$80.9K Hold
1,181
– – ﹤0.01% 401
2023
Q4 		$68.3K Buy
1,181
+687
+139% +$36.7K 0.01% 433
2023
Q3 		$26.1K Hold
494
– – ﹤0.01% 576
2023
Q2 		$26.7K Hold
494
– – ﹤0.01% 592
2023
Q1 		$24.7K Hold
494
– – ﹤0.01% 598
2022
Q4 		$22.9K Buy
+494
New +$21.4K ﹤0.01% 587

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Hollencrest Capital Management's BSX Position: Q2 2026 in Review

Hollencrest Capital Management held its Boston Scientific (BSX) position steady in Q2 2026 at 1,181 shares worth $50.4K. The position accounts for ﹤0.01% of the portfolio, ranked #568.

Hollencrest Capital Management first reported a position in BSX in Q4 2022 and has held it in 15 quarters since. The position peaked at $127K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Hollencrest Capital Management held 1,181 shares of Boston Scientific worth $50.4K as of Q2 2026.
  • Hollencrest Capital Management left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up ﹤0.01% of Hollencrest Capital Management's portfolio in Q2 2026, its #568 holding.
  • Hollencrest Capital Management first reported a position in Boston Scientific in Q4 2022 and has held it in 15 quarters since.
  • Hollencrest Capital Management's Boston Scientific position peaked at $127K in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.